Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
about
CYP3A4 overexpression enhances apoptosis induced by anticancer agent imidazoacridinone C-1311, but does not change the metabolism of C-1311 in CHO cells.Tissue-specific regulation of pregnane X receptor in cancer development and therapy.Real-time polymerase chain reaction.Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel ChemotherapyThe role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patientsMechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.Drug metabolism by tumours: its nature, relevance and therapeutic implications.WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel.Toward a new age of cellular pharmacokinetics in drug discovery.Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model.Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8.Standardization of the infusion sequence of antineoplastic drugs used in the treatment of breast and colorectal cancers.Association between Changes in Serum 25-Hydroxyvitamin D Levels and Survival in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.
P2860
Q33823679-48318886-9402-49FA-8E7A-A5888602B307Q34545411-1716EC50-D339-4F43-9360-43F0CCC5C4E4Q35581898-5D4EF453-47DB-46B9-837A-E5641C7A95ABQ35862309-6AF39A25-58A0-43A4-BD5B-123B2E9FFAB4Q36154045-3FE30E94-C296-45D3-B259-FED9AB3F9964Q36589865-92DB091C-2BA7-457C-B3D0-1AB8DD0AF0CDQ37008879-CBCE34DD-C96E-4A9D-BC6C-12B5E13876C9Q37721627-EEAA2785-198D-4D3D-B252-C58230ADBEBBQ37851981-E3EF10AF-383A-48C5-A40F-5C87CD382CBBQ38686308-E39185BB-C751-4C85-B930-E14C8B8D81BBQ39090000-ECBD85C0-81E1-47BD-B790-A71EEEDA1007Q40617502-4EBDF7F5-3D49-445F-91C1-0E2E50A47081Q42496419-5AAAF723-BA7A-4028-87E3-FC31554836F7Q55111817-981C16CB-8ECF-4E57-AB72-BFE5E42AAC4BQ55365832-220D1DD1-E44F-4F5E-AD6E-32C747D6E293
P2860
Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
@en
Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
@nl
type
label
Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
@en
Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
@nl
prefLabel
Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
@en
Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
@nl
P2093
P2860
P356
P1476
Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
@en
P2093
Akiko Ando
Shinzaburo Noguchi
Tetsuya Taguchi
Yasuhiro Tamaki
Yasuo Miyoshi
Yuuki Takamura
P2860
P304
P356
10.1002/IJC.1568
P577
2002-01-01T00:00:00Z